Related references
Note: Only part of the references are listed.Comparison of Allogeneic Hematopoietic Cell Transplantation and Chemotherapy in Elderly Patients with Non-M3 Acute Myelogenous Leukemia in First Complete Remission
Saiko Kurosawa et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
The negative impact of female donor/male recipient combination in allogeneic hematopoietic stem cell transplantation depends on disease risk
Yasuhito Nannya et al.
TRANSPLANT INTERNATIONAL (2011)
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
Hartmut Doehner et al.
BLOOD (2010)
Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
Vikas Gupta et al.
BLOOD (2010)
Prospective Evaluation of Allogeneic Hematopoietic Stem-Cell Transplantation From Matched Related and Matched Unrelated Donors in Younger Adults With High-Risk Acute Myeloid Leukemia: German-Austrian Trial AMLHD98A
Richard F. Schlenk et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Comparison of matched unrelated and matched related donor myeloablative hematopoietic cell transplantation for adults with acute myeloid leukemia in first remission
R. B. Walter et al.
LEUKEMIA (2010)
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation
Olle Ringden et al.
BLOOD (2009)
Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Systematic Review and Meta-analysis of Prospective Clinical Trials
John Koreth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Optimal induction and post-remission therapy for AML in first remission
J. M. Rowe
Hematology-American Society of Hematology Education Program (2009)
Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation
M. Stern et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Transplantation from matched siblings using once-daily intravenous busulfan/fludarabine with thymoglobulin: A myeloablative regimen with low nonrelapse mortality in all but older patients with high-risk disease
James A. Russell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Matched Unrelated or Matched Sibling Donors Result in Comparable Survival After Allogeneic Stem-Cell Transplantation in Elderly Patients With Acute Myeloid Leukemia: A Report From the Cooperative German Transplant Study Group
Johannes Schetelig et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F. Schlenk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation
Stephanie J. Lee et al.
BLOOD (2007)
Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP system
Yoshiko Atsuta et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2007)
Competing risk analysis using R: an easy guide for clinicians
L. Scrucca et al.
BONE MARROW TRANSPLANTATION (2007)
Equivalent survival for sibling and unrelated donor allogeneic stem cell transplantation for acute myelogenous leukemia
John Moore et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2007)
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?
Jan J. Cornelissen et al.
BLOOD (2007)
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations
H Oh et al.
BLOOD (2005)
Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS
M de Lima et al.
BLOOD (2004)
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants
SSB Randolph et al.
BLOOD (2004)
Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CRI): an intention-to-treat analysis of the EORTC/GIMEMA AML-10 trial
S Suciu et al.
BLOOD (2003)
The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: Results of the UK MRC AML 10 trial
AK Burnett et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Share Paper
